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Disruption of the P450 side-chain cleavage cytochrome
(P450scc) enzyme due to deleterious mutations of the CYP11A1
gene is thought to be incompatible with fetal survival because
of impaired progesterone production by the fetoplacental
unit. We present a 46,XY patient with a homozygous disrup-
tion of CYP11A1.
The child was born prematurely with complete sex reversal
and severe adrenal insufficiency. Laboratory data showed di-
minished or absent steroidogenesis in all pathways. Molecu-
lar genetic analysis of the CYP11A1 gene revealed a homozy-
gous single nucleotide deletion leading to a premature
termination at codon position 288. This mutation will delete
highly conserved regions of the P450scc enzyme and thus is
predicted to lead to a nonfunctional protein. Both healthy
parents were heterozygous for this mutation.
Our report demonstrates that severe disruption of P450scc
can be compatible with survival in rare instances. Further-
more, defects in this enzyme are inherited in an autosomal-
recessive fashion, and heterozygote carriers can be healthy
and fertile. The possibility of P450scc-independent pathways
of steroid synthesis in addition to the current concept of lu-
teoplacental shift of progesterone synthesis in humans has to
be questioned. (J Clin Endocrinol Metab 90: 538–541, 2005)
C
HOLESTEROL SIDE-CHAIN CLEAVAGE cytochrome
P450 (P450scc) is a key regulator of steroidogenesis.
P450scc is a single mitochondrial enzyme that involves ad-
renodoxin and nicotinamide adenine dinucleotide phos-
phate reduced adrenodoxin reductase. P450scc catalyzes the
conversion of cholesterol to pregnenolone as the first and
rate-limiting step in the biosynthesis of all steroid hormones.
P450scc is necessary, therefore, for fetal and postnatal glu-
cocorticoid, mineralocorticoid, and sex steroid biosynthesis.
Disruption of these early steroidogenic pathways leads to
accumulation of cholesterol in the adrenal cortex, causing
congenital lipoid adrenal hyperplasia (CLAH). CLAH is due
to severe impairment of conversion of cholesterol to preg-
nenolone both in the adrenals and gonads in utero and post-
natally, resulting in salt wasting and lack of virilization.
CLAH is believed to occur as a two-stage event, during
which the initial genetic loss is aggravated by subsequent
cellular damage due to accumulation of cholesterol ethers
with gross enlargement of the adrenal glands (1). Recently it
was reported that CLAH is not due to defects in P450scc but
rather to changes in steroidogenic acute regulatory protein
(StAR), which facilitates cholesterol entry into the mitochon-
dria to induce an acute response of steroid synthesis (1, 2).
P450scc is essential for progesterone synthesis in all
steroidogenic tissues in primates. However, several tis-
sues including the placenta maintain steroidogenesis in-
dependent of StAR (3). In normal primate pregnancies, the
maternal corpus luteum produces progesterone in the first
trimester but the fetally derived placenta takes over pro-
gesterone production from the second trimester to term
(luteoplacental shift) (4). Thus, the current paradigm is
that pregnancies with fetal StAR deficiency are not com-
promised, whereas severe disruption of P450scc would be
incompatible with term pregnancy in humans, and affected
fetuses would not be viable (5). In rabbits, in which the
pregnancy is supported by progesterone synthesis by the
maternal corpus luteum, a naturally occurring deletion of
P450scc has been described, demonstrating the phenotype of
this deficiency and also proving an autosomal-recessive in-
heritance mode for the disorder (6). To date, only two pa-
tients have been reported with P450scc deficiency due to
molecular abnormalities of the CYP11A1 gene. In one patient
P450scc haploinsufficiency due to a heterozygous mutation
was reported (7). In the second patient, compound heterozy-
gous mutations of P450scc partially inactivated the enzyme
in in vitro experiments. However, clinical manifestation of
CLAH did not occur until the seventh month of life. Thus, in
vivo steroidogenesis had been sufficient throughout the neo-
natal period (8).
P450scc is encoded by the CYP11A1 gene, which is 29 kb
long and consists of nine exons and eight introns. The re-
sulting protein is 521 amino acids in length and contains a
highly conserved heme binding site as well as a mitochon-
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538drial transport signal (9). We report the first patient with
a homozygous small deletion mutation in CYP11A1 lead-
ing to a premature termination of P450scc. This mutation
was inherited in an autosomal-recessive fashion from
healthy parents. The resulting enzyme will lack a major
part of the protein structure including the heme binding
motif and thus be nonfunctional. The child was born pre-
maturely with severe adrenal insufficiency present in the
first days of life. Furthermore, the 46,XY patient presented
with complete sex reversal. This is the first description of
an inherited disruptive mutation in the CYP11A1 gene.
Thus, in rare cases, children with complete P450scc defi-
ciency may survive.
Case Report
The child was born at 31 wk gestation to nonconsan-
guineous Caucasian parents. The 31-yr-old mother had a
history of two early miscarriages and had two healthy
children (Fig. 1A). During this pregnancy, low maternal
plasmaestriol[0.2ng/ml(0.69nmol/liter);reference1.55–
1.95 ng/ml] was detected in the 18th gestational wk,
promptingamniocentesisanddeterminationof46,XYfetal
karyotype. The mother received betamethasone to induce
fetal lung maturation because of impending preterm de-
livery in the 30th wk of gestation. Progesterone was not
given and 4 d later, the child was born by cesarean section
due to unavoidable labor. Surprisingly, the baby’s phe-
notype was unequivocally female with an unusual bronze
skin color. After an uneventful postpartal period, the child
developed signs of adrenal insufficiency with serum so-
dium of 123 mmol/liter, potassium of 5.2 mmol/liter, and
blood glucose of 31 mg/dl (1.7 mmol/liter) on d 9 post
partum. Hydrocortisone in a dose of 40 mg/m
2 was given
because congenital adrenal hyperplasia was suspected but
was discontinued on d 21 because a transient adrenal
insufficiency was suspected and the prenatal determined
karyotype was not known at this time. Within 24 h, the
child again developed signs of severe salt wasting with
serum sodium 123 mmol/liter and potassium 6.6 mmol/
liter. Blood glucose was 59 mg/dl (3.2 mmol/liter), blood
pressurewas31/18mmHg.Thechilddevelopedrespiratory
failure and was put on a respiratory ventilator. At this time,
plasmaACTHwasexcessivelyelevatedat2789ng/liter(nor-
mal  60 ng/liter) and plasma renin activity was more than
3200 ng/liter (normal  308 ng/liter). Plasma cortisol and
17-hydroxyprogesterone were undetectable, consistent with
severe glucocorticoid and mineralocorticoid deficiency.
Treatment with hydrocortisone and fludrocortisone was
commenced,andthechildimprovedrapidly.Urinarysteroid
analysis at the age of 2 months did not demonstrate any
excretion of 3-hydroxy-5-ene steroids, suggesting complete
loss of steroidogenesis. The 46,XY karyotype was confirmed.
Therefore, a presumptive diagnosis of congenital lipoid ad-
renal hyperplasia was made. At the age of 2 yr, medication
was discontinued under medical supervision. Within 24 h,
the child went into adrenal crisis. Although ACTH was nor-
mal on treatment, severe adrenal insufficiency was evident
from plasma hormone levels determined in adrenal crisis
(Table1).Ultrasoundandmagneticresonanceimagingfailed
FIG. 1. Localization and pattern of inheri-
tance of the CYP11A1 gene mutation. A,
Pedigree of the family, indicating the ho-
mozygous propositus, the heterozygous par-
ents, two healthy siblings with unknown ge-
netic status, and two previous miscarriages.
B, Single-strand conformation polymor-
phism/heteroduplex analysis demonstrates
the heterozygous status of the parents and
homozygous status of their child. C, Electro-
pherograms of DNA sequences confirm the
heterozygous deletion of an adenine within
exon 5 of CYP11A1 in the parents and the
homozygous deletion of this nucleotide in
their child. D, The deletion of adenine in
codon 279 (arrow) leads to a frame shift and
premature stop codon at position 288 (un-
derlined). The intron 4/exon 5 boundary is
indicated by lower-/uppercase letters.
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seen.
Materials and Methods
Molecular genetic analysis of CYP11A1 was performed using pub-
lished primer sequences (7, 9). All exons were amplified by PCR and
subsequently investigated with single-strand conformation polymor-
phism analysis. An aberrant migration pattern of the patient’s DNA
amplification product was detected in exon 5 (Fig. 1B). This exon was
subjected to direct sequencing on an automated sequencer after ream-
plification from DNA of the patient and her parents. Molecular analysis
of the genes encoding StAR and steroidogenic factor-1 (SF-1, NR5A1)
was also performed and did not reveal any abnormalities. DNA from a
normal male was used as a negative control. Informed consent was
obtained for studies of the propositus and the parents. The parents did
not consent to studying their healthy children.
Results
We detected a homozygous deletion of adenine at nucle-
otide position 835 in exon 5 of CYP11A1 in the proband,
leading to a frame shift within codon 278 and a premature
termination codon at position 288 (Fig. 1 C and D). Both
parents were heterozygous for this single nucleotide change
(Fig. 1), thus confirming autosomal-recessive inheritance of
this mutation. The detected mutation is predicted to cause
deletion of the carboxy-terminal 242 amino acids of the
P450scc enzyme, a region containing the highly conserved
heme binding site, a critical meander domain involved in the
interaction of P450scc with its electron transfer partners, and
several conserved adrenodoxin binding sites (10–12). The
importanceofthisregionforP450sccfunctionhaspreviously
been demonstrated by point mutations that abolish choles-
terol side chain cleavage (R426Q) or heme binding (R425Q)
(10). Therefore, this homozygous 835delA mutation is
unlikely to be compatible with expression of a functional
P450scc enzyme.
Discussion
Our report demonstrates that, in rare cases, fetuses with
inherited homozygous disruptive mutations of the CYP11A1
gene may be viable. The single nucleotide deletion detected
in the patient as well as the parents leading to an early
premature termination codon implies that the resulting pro-
tein will be completely nonfunctional. Due to this obvious
molecular impact, functional studies were not performed. It
has to be postulated that maternal steroids have contributed
to survival of the child. However, it is also unclear why
progesterone and 17-hydroxypregnenolone were detectable
after discontinuation of treatment at the age of 2 yr. This may
imply that subtle P450scc-independent mechanisms of pro-
gesteronesynthesismayexist,butthishypothesisshouldnot
be drawn from a single case presentation. Also, whether the
earliermiscarriagesreportedbythemotherwereduetoother
affected pregnancies with homozygous CYP11A1 mutation
remains unknown because investigation of abortive material
was not performed at that time because the molecular ab-
erration in the affected child was unknown.
This CYP11A1 mutation was inherited from heterozygous
but healthy parents, proving that heterozygosity for a dis-
ruptive mutation allows sufficient steroid production for
normal adrenal function, sexual differentiation, and fertility.
Investigation of the mother revealed normal levels of LH,
FSH, ACTH, and plasma renin as well as estradiol, proges-
terone, and cortisol. Electrolytes were normal.
The gonads of this child have differentiated normally be-
cause they produced sufficient antimu ¨llerian hormone to
induce regression of Mu ¨llerian structures during early fetal
development. However, because gonadal structures were
notdetectablebyultrasoundormagneticresonanceimaging,
we assume that very early secondary atrophy may have
occurred due to cholesterol accumulation comparable with
mechanisms observed in patients with StAR defects in later
childhood (1). Because surgical procedures have not taken
place yet, the exact structure of these organs or the histology
of remnants is still unknown.
Recently two reports of patients with partial inactivating
mutations of P450scc have been published. One 46,XX pa-
tientwhopresentedwithadrenalinsufficiencyinlateinfancy
was found to be compound heterozygous for two point mu-
tations inducing amino acid substitutions. One of these ex-
changespartiallyreducedP450sccactivity,whereastheother
change was predicted to create a novel splice-donor site (8).
The other patient, a 46,XY child with clitoromegaly and ad-
renal failure at 4 yr of age, carried only one heterozygous
mutation, which completely abolished enzyme activity in
vitro (7). The authors postulated that haploinsufficiency of
P450scc resulted in subnormal responses to ACTH. This in
turn induced cellular damage by cholesterol accumulation
due to recurrent ACTH stimulation, finally resulting in
adrenal insufficiency. Of note, both previously reported
subjects were born after normal pregnancies and did not
present with severe illness during the neonatal period, im-
plying sufficient placental progesterone synthesis during
pregnancy.
Several examples of the combination of sex reversal and
adrenal insufficiency in 46,XY infants have been reported so
far. Mutations of the gene encoding SF-1 cause a similar
phenotype as the homozygous CYP11A1 mutation described
here (13). Mullerian structures may be present due to early
gonadal failure. However, in a recent report, a heterozygous
TABLE 1. Hormone analysis at the age of 2 yr after discontinuation of steroid medication for 24 h demonstrated highly elevated ACTH
and low or undetectable levels of steroid hormones
ACTH
(ng/liter)
Progesterone
(ng/ml)
17-OH-pregnenolone
(ng/ml)
17-OHP
(ng/ml)
Aldosterone
(ng/ml)
Cortisol
(ng/ml)
DHEA
(ng/ml)
Patient 479 0.12 0.38 0.01 0.02 2.0 0.05
Normal age range (1–3 yr) 60 0.6–0.74 0.4–2.4 0.03–0.95 0.1–0.79 17.1–137.0 1.0–785.0
Normal age ranges according to Refs. 18 and 19. Conversion factors (SI) are: for progesterone  3.18; for 17-OH-pregnenolone  3.006; for
17-OHP  3.026; for aldosterone  2.774; for cortisol  2.759; and for DHEA  3.47. 17-OHP, 17-Hydroxyprogesterone; DHEA, dehydroepi-
androsterone.
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associated with 46,XY sex reversal without adrenal insuffi-
ciency or the presence of Mullerian structures, demonstrat-
ing that during embryogenesis gonads and throughout life,
adrenals were functional (14). Mutations in the StAR gene
lead to CLAH with secondary adrenal and gonadal atrophy
in childhood (1, 2, 15–17). Hence, P450scc deficiency due to
homozygousdisruptivemutationsoftheCYP11A1genemay
betheultimatecauseofCLAH,withearlysecondaryatrophy
of steroid producing organs during fetal life. This finding is
consistent with earlier observations in rabbits, in which ho-
mozygousdisruptionofP450sccleadstoasimilarphenotype
and heterozygote carriers are healthy and fertile (6). In con-
trast to humans, affected rabbits are thought to survive preg-
nancybecauseprogesteroneproductionismaintainedbythe
corpus luteum rather than the placenta. The case presented
here may dispute the existing paradigm of the luteoplacental
shiftofsteroidogenesisinhumanswithalternativepathways
of progesterone synthesis. It may also have implications for
CYP11A1 mutations as an inherited cause of recurrent early
fetal loss.
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